Infant Bacterial Therapeutics AB (publ) (IBT-B) — Working Capital to Net Assets Ratio
Infant Bacterial Therapeutics AB (publ) (IBT-B) has a Working Capital to Net Assets ratio of 93.3% as of September 2025. Working capital of Skr116.02 Million (current assets of Skr169.88 Million minus current liabilities of Skr53.87 Million) is measured against net assets of Skr124.36 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See IBT-B days of operational coverage to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Infant Bacterial Therapeutics AB (publ) Working Capital to Net Assets (2013–2024)
This chart shows how Infant Bacterial Therapeutics AB (publ)'s Working Capital to Net Assets ratio has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the ratio stands at 93.3%, reflecting working capital of Skr116.02 Million against net assets of Skr124.36 Million SEK. For the complete balance sheet picture, see balance sheet size of Infant Bacterial Therapeutics AB (publ).
Annual Working Capital to Net Assets for Infant Bacterial Therapeutics AB (publ) (2013–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Infant Bacterial Therapeutics AB (publ) from 2013 to 2024, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check financial resilience of Infant Bacterial Therapeutics AB (publ) to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (SEK) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 94.7% | Skr161.31 Million | Skr170.26 Million | Skr230.61 Million | Skr69.30 Million | ▼ -2.1 pp |
| 2023 | 96.8% | Skr295.38 Million | Skr305.15 Million | Skr341.56 Million | Skr46.18 Million | ▼ 0.0 pp |
| 2022 | 96.8% | Skr321.12 Million | Skr331.71 Million | Skr339.03 Million | Skr17.91 Million | ▼ -0.3 pp |
| 2021 | 97.1% | Skr383.87 Million | Skr395.25 Million | Skr397.09 Million | Skr13.22 Million | ▼ -0.1 pp |
| 2020 | 97.2% | Skr427.95 Million | Skr440.15 Million | Skr438.12 Million | Skr10.16 Million | ▼ -0.2 pp |
| 2019 | 97.4% | Skr497.38 Million | Skr510.40 Million | Skr505.26 Million | Skr7.88 Million | ▼ -0.1 pp |
| 2018 | 97.5% | Skr542.88 Million | Skr556.72 Million | Skr549.54 Million | Skr6.65 Million | ▲ +6.2 pp |
| 2017 | 91.3% | Skr153.72 Million | Skr168.37 Million | Skr160.38 Million | Skr6.65 Million | ▲ +5.9 pp |
| 2016 | 85.4% | Skr89.81 Million | Skr105.23 Million | Skr94.69 Million | Skr4.88 Million | ▲ +7.0 pp |
| 2015 | 78.3% | Skr58.58 Million | Skr74.81 Million | Skr66.32 Million | Skr7.73 Million | ▲ +33.4 pp |
| 2014 | 44.9% | Skr4.96 Million | Skr11.03 Million | Skr8.46 Million | Skr3.51 Million | ▼ -55.1 pp |
| 2013 | 100.0% | Skr1.05 Million | Skr1.05 Million | Skr1.29 Million | Skr240.70K | — |